BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1
742 results:

  • 1. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
    Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
    Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combining fecal microbiome and metabolomics reveals diagnostic biomarkers for esophageal squamous cell carcinoma.
    Gao M; Wu J; Zhou S; Chen Y; Wang M; He W; Jiang L; Shu Y; Wang X
    Microbiol Spectr; 2024 May; 12(5):e0401223. PubMed ID: 38497715
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma.
    Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
    Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study.
    Chen QY; Guo SS; Luo Y; Qu S; Wu DH; Chen XZ; Chen DP; Qin XT; Lin Q; Jin F; Lin SJ; Yao ZF; Liu W; Maxwell Wang Z; Li BY; Xia M; Xu RH; Tang LQ; Mai HQ
    Oral Oncol; 2024 Apr; 151():106723. PubMed ID: 38387261
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring the role of ubiquitin regulatory X domain family proteins in cancers: bioinformatics insights, mechanisms, and implications for therapy.
    Yang E; Fan X; Ye H; Sun X; Ji Q; Ding Q; Zhong S; Zhao S; Xuan C; Fang M; Ding X; Cao J
    J Transl Med; 2024 Feb; 22(1):157. PubMed ID: 38365777
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Semilicoisoflavone B induces oral cancer cell apoptosis by targeting claspin and ATR-Chk1 signaling pathways.
    Hsieh MJ; Lin CC; Lo YS; Chuang YC; Ho HY; Chen MK
    Environ Toxicol; 2024 Apr; 39(4):2417-2428. PubMed ID: 38197544
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NGAL Mediates Anaplastic Thyroid Carcinoma Cells Survival Through fas/cd95 Inhibition.
    Crescenzi E; Mellone S; Gragnano G; Iaccarino A; Leonardi A; Pacifico F
    Endocrinology; 2023 Dec; 165(2):. PubMed ID: 38091978
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
    Sun MY; Wang L; Shen ZY
    Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic utility of preoperative platelet-to-albumin ratio in surgically treated oral cavity cancer patients.
    Tsai YT; Fang KH; Tsai MH; Lai CH; Ko CA; Tsai MS; Chang GH; Liao CT; Kang CJ; Hsu CM; Huang EI; Lee YC; Tsai YH; Luan CW
    Head Neck; 2024 Feb; 46(2):386-397. PubMed ID: 38071495
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.
    Hsieh MJ; Lin CC; Lo YS; Ho HY; Chuang YC; Chen MK
    J Cell Mol Med; 2024 Jan; 28(2):e18071. PubMed ID: 38044583
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. NIFTPs may be reclassified not only from FVPTCs but also from follicular adenomas.
    Albuquerque Pinto Rebello I; Loures de Oliveira V; Abbud LFH; Aprígio Camargos Ferreira T; Vidal APA; de Fátima Dos Santos Teixeira P
    Endocr Relat Cancer; 2024 Feb; 31(2):. PubMed ID: 38029301
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Sodium Levels and Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving Nivolumab.
    Catalano M; Rebuzzi SE; Maruzzo M; De Giorgi U; Buti S; Galli L; Fornarini G; Zucali PA; Procopio G; Chiellino S; Milella M; Catalano F; Pipitone S; Ricotta R; Sorarù M; Mollica V; Tudini M; Fratino L; Prati V; Caffo O; Atzori F; Morelli F; Prati G; Nolè F; Vignani F; Cavo A; Di Napoli M; Malgeri A; Naglieri E; Signori A; Banna GL; Rescigno P; Antonuzzo L; Roviello G
    JAMA Netw Open; 2023 Nov; 6(11):e2345185. PubMed ID: 38010650
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sex- and gender-specific differences in symptoms and health-related quality of life among patients with gastroesophageal reflux disease.
    Pelzner K; Fuchs C; Petersen M; Maus M; Bruns CJ; Leers JM
    Dis Esophagus; 2024 Feb; 37(3):. PubMed ID: 37963417
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiotherapy and long-term sequelae in pediatric patients with parameningeal rhabdomyosarcoma: Results of two Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
    Sparber-Sauer M; Dietzschold M; Schönstein A; Heinz A; Vokuhl C; Pajtler KW; Harrabi S; Lin YL; Kalle TV; Hagen R; Ladenstein R; Kazanowska B; Ljungman G; Klingebiel T; Ebinger M; Koscielniak E; Münter M; Timmermann B;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30742. PubMed ID: 37880926
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Related factors of high-volume lymph node metastasis in multifocal papillary thyroid carcinoma].
    Hu CF; Zhang T; Wei PY; Cao HJ; Han ZJ
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3199-3203. PubMed ID: 37879874
    [No Abstract]    [Full Text] [Related]  

  • 16. Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients.
    Ferreira AMC; Altemani JMC; Macedo LT; Lourenço GJ; Lima CSP
    Sci Rep; 2023 Oct; 13(1):16762. PubMed ID: 37798436
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Strategy for characterization and quantification of fatty acids in plasma by parallel d
    Li J; Xu J; Zhang R; He J; Wang M; Jiao G; Abliz Z
    Talanta; 2024 Jan; 267():125231. PubMed ID: 37783107
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial.
    Reynolds JV; Preston SR; O'Neill B; Lowery MA; Baeksgaard L; Crosby T; Cunningham M; Cuffe S; Griffiths GO; Parker I; Risumlund SL; Roy R; Falk S; Hanna GB; Bartlett FR; Alvarez-Iglesias A; Achiam MP; Nilsson M; Piessen G; Ravi N; O'Toole D; Johnston C; McDermott RS; Turkington RC; Wahed S; Sothi S; Ford H; Wadley MS; Power D;
    Lancet Gastroenterol Hepatol; 2023 Nov; 8(11):1015-1027. PubMed ID: 37734399
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Silencing POLE2 promotes apoptosis and inhibits proliferation of oral squamous cell carcinomas by inhibiting PI3K/AKT signaling pathway.
    Ge S; Wang K; Meng Y; He Z; Yang X; Shang W; Wang L
    Med Oncol; 2023 Sep; 40(10):304. PubMed ID: 37733085
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Implementing the first program of minimally invasive esophagectomy for cancer in Israel: shifting the paradigm in a high-volume center - a cohort study.
    Solomon D; Sarfaty E; Menasherov N; Bard V; Bueno R; Kashtan H
    Int J Surg; 2023 Nov; 109(11):3467-3475. PubMed ID: 37678317
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 38.